Source: Business Insider
Foundayo, the new GLP-1 weight loss pill from Eli Lilly, was approved by the Food and Drug Administration on April 1. Eli LillyFoundayo, a new weight loss pill from Eli Lilly, is the first oral GLP-1 that doesn't require fasting. In clinical trials, people lost an average of 8-25 pounds on the drug.
Aller á la Source
Nouvelles connexes
